Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors
NCT04738162
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
78
Enrollment
OTHER
Sponsor class
Conditions
Brain Tumor, Pediatric
Interventions
DRUG:
5-Aminolevulinic Acid Hydrochloride, Oral
Sponsor
Universität Münster
Collaborators
[object Object]
[object Object]